International Conference on Type 1 Diabetes Research

ICT1DR

5th Mar – 6th Mar 2027 Copenhagen, Denmark

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Read the full Terms & Conditions

Registration Summary

Conference ICT1DR

Date 5th Mar – 6th Mar 2027

Location Copenhagen, Denmark

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Pathophysiology of Type 1 Diabetes +

This track will explore the underlying mechanisms that contribute to the onset and progression of type 1 diabetes. Emphasis will be placed on the interplay between genetic predisposition and environmental triggers.

SDG 3 SDG 4

02 Autoimmunity in Type 1 Diabetes +

This session will focus on the autoimmune processes that lead to beta-cell destruction in type 1 diabetes. Researchers are encouraged to present findings on immune system dysregulation and potential therapeutic targets.

SDG 3 SDG 4

03 Genetic Factors in Type 1 Diabetes +

This track will delve into the genetic determinants associated with type 1 diabetes susceptibility. Discussions will include recent advancements in genomics and their implications for personalized medicine.

SDG 3 SDG 9

04 Clinical Trials and Therapeutic Innovations +

This session will highlight the latest clinical trials aimed at improving treatment outcomes for individuals with type 1 diabetes. Participants will share insights on novel therapies and their efficacy in diverse populations.

SDG 3 SDG 4

05 Biomarkers for Type 1 Diabetes +

This track will investigate the identification and validation of biomarkers for early diagnosis and disease progression in type 1 diabetes. The focus will be on how biomarkers can inform treatment strategies and patient management.

SDG 3 SDG 9

06 Advancements in Insulin Therapy +

This session will cover recent innovations in insulin delivery and formulation for type 1 diabetes management. Presentations will include discussions on the impact of technology on patient adherence and glycemic control.

SDG 3 SDG 4

07 Pediatric Diabetes: Challenges and Solutions +

This track will address the unique challenges faced by children and adolescents with type 1 diabetes. Emphasis will be placed on psychosocial aspects, education, and the transition to adult care.

SDG 3 SDG 4

08 Disease Mechanisms and Complications +

This session will explore the complex mechanisms that contribute to the complications associated with type 1 diabetes. Researchers will present findings on cardiovascular, renal, and neurological complications.

SDG 3 SDG 9

09 Translational Research in Type 1 Diabetes +

This track will focus on bridging the gap between laboratory research and clinical application in type 1 diabetes. Discussions will highlight successful case studies and the role of interdisciplinary collaboration.

SDG 3 SDG 4

10 Psychosocial Aspects of Living with Type 1 Diabetes +

This session will examine the psychological and social challenges faced by individuals living with type 1 diabetes. Topics will include coping strategies, mental health support, and the impact of diabetes on quality of life.

SDG 3 SDG 4

11 Future Directions in Type 1 Diabetes Research +

This track will provide a platform for discussing emerging trends and future research directions in type 1 diabetes. Participants are encouraged to propose innovative ideas and collaborative approaches to advance the field.

SDG 3 SDG 9